Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
© Anthoney et al.; licensee BioMed Central Ltd. 2012
Received: 29 February 2012
Accepted: 6 November 2012
Published: 21 November 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|29 Feb 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|5 Mar 2012||Author responded||Author comments - KEITH JONES|
|Resubmission - Version 3|
|5 Mar 2012||Submitted||Manuscript version 3|
|25 Mar 2012||Reviewed||Reviewer Report - Laurent Rivory|
|7 Apr 2012||Reviewed||Reviewer Report - Mark McKeage|
|28 May 2012||Author responded||Author comments - KEITH JONES|
|Resubmission - Version 4|
|28 May 2012||Submitted||Manuscript version 4|
|6 Nov 2012||Editorially accepted|
|21 Nov 2012||Article published||10.1186/1471-2407-12-536|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.